![]() |
|
|
Vol. 293, Issue 2, 509-513, May 2000
Unitat de Bioquímica, Departament de Ciències
Fisiològiques II, Campus de Bellvitge, Universitat de Barcelona,
L'Hospitalet, Barcelona, Spain
NS-398
[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide],
a selective inhibitor of cyclooxygenase-2 (COX-2), inhibited proliferation induced by platelet-derived growth factor (PDGF) in Swiss
3T3 fibroblasts. The effect of NS-398 was found to be concentration-dependent. The half-maximal effect occurred at ~0.1 µM. NS-398 decreased mitogenesis at subsaturating PDGF concentrations and the inhibitory effect of NS-398 was overcome by increasing PDGF
concentration. SC-236, another COX-2 selective inhibitor, also
inhibited PDGF-induced proliferation. In contrast, two selective COX-1
inhibitors, valeryl salicylate and ketorolac, had no significant inhibitory effect on PDGF-stimulated DNA synthesis. The inhibition was
obtained when NS-398 was added during the first hour after PDGF
addition. At 1 h, PDGF induced COX-2 protein and prostaglandin (PG)E2 synthesis, and NS-398 blocked the synthesis of
PGE2. The inhibitory effect of NS-398 on PDGF-stimulated
DNA synthesis was counteracted by 280 nM PGE2. The
antimitogenic action of NS-398 and SC-236 suggests that selective
inhibition of COX-2 may produce antiproliferative effects with
substantial safety advantages over nonselective COX inhibitors.
This article has been cited by other articles:
![]() |
A. Lee, J. Frischer, A. Serur, J. Huang, J.-O Bae, Z. N. Kornfield, L. Eljuga, C. J. Shawber, N. Feirt, M. Mansukhani, et al. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Res., April 15, 2006; 66(8): 4378 - 4384. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Kim, H.-J. Jeong, I.-Y. Choi, K.-M. Lee, R.-K. Park, S.-H. Hong, and H.-M. Kim Cyclooxygenase-2 Inhibitor SC-236 [4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-l] Benzenesulfonamide] Suppresses Nuclear Factor-{kappa}B Activation and Phosphorylation of p38 Mitogen-Activated Protein Kinase, Extracellular Signal-Regulated Kinase, and c-Jun N-Terminal Kinase in Human Mast Cell Line Cells J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 27 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tortora, R. Caputo, V. Damiano, D. Melisi, R. Bianco, G. Fontanini, B. M. Veneziani, S. De Placido, A. R. Bianco, and F. Ciardiello Combination of a Selective Cyclooxygenase-2 Inhibitor with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 and Protein Kinase A Antisense Causes Cooperative Antitumor and Antiangiogenic Effect Clin. Cancer Res., April 1, 2003; 9(4): 1566 - 1572. [Abstract] [Full Text] [PDF] |
||||